Son S, Woo C
J Int Med Res. 2024; 52(12):3000605241310843.
PMID: 39719071
PMC: 11682585.
DOI: 10.1177/03000605241310843.
Bahl V, Bahl A
Indian J Otolaryngol Head Neck Surg. 2024; 76(2):2158-2161.
PMID: 38566663
PMC: 10982151.
DOI: 10.1007/s12070-023-04426-5.
DE Azeredo S, Correa N, Martio A, Mesquita Filho P
Curr Health Sci J. 2024; 49(4):597-600.
PMID: 38559838
PMC: 10976204.
DOI: 10.12865/CHSJ.49.04.17.
He L, Zhang J, Zhu T, Zhao P, Mou P, Tang S
Cancer Med. 2024; 13(3):e6831.
PMID: 38230983
PMC: 10905223.
DOI: 10.1002/cam4.6831.
Fattahi M, Zarafshani M, Abdolahad M, Jalaeefar A, Mahdavi R, Yousefpour N
Clin Case Rep. 2023; 11(10):e7995.
PMID: 37822486
PMC: 10562655.
DOI: 10.1002/ccr3.7995.
Epidemiology and survival outcomes of patients with orbital region non-cutaneous squamous cell carcinoma: a population-based analysis.
He L, Mou P, Wei R
Front Oncol. 2023; 13:1152337.
PMID: 37213302
PMC: 10196690.
DOI: 10.3389/fonc.2023.1152337.
Lacrimal Gland Adenoid Cystic Carcinoma with High Grade Transformation: A Case Report and Current Concepts in Multi Modality Management.
Shah S, Parikh L, Solanki R, Bhojani J, Gohil R
Indian J Otolaryngol Head Neck Surg. 2022; 74(Suppl 2):2599-2606.
PMID: 36452811
PMC: 9702296.
DOI: 10.1007/s12070-020-02277-y.
Lacrimal gland pleomorphic adenoma: a narrative review.
Horochoski L, Schulz G, Koerbel A
Arq Bras Oftalmol. 2022; .
PMID: 36350911
PMC: 11627166.
DOI: 10.5935/0004-2749.2022-0057.
Lacrimal gland adenoid cystic carcinoma: report of an unusual case with literature review.
Benali K, Benmessaoud H, Aarab J, Nourreddine A, El Kacemi H, Majjaoui S
Radiat Oncol J. 2021; 39(2):152-158.
PMID: 34619831
PMC: 8497861.
DOI: 10.3857/roj.2021.00122.
Rare Diseases of the Orbit.
Kisser U, Heichel J, Glien A
Laryngorhinootologie. 2021; 100(S 01):S1-S79.
PMID: 34352903
PMC: 8365778.
DOI: 10.1055/a-1384-4641.
Retrospective Analysis of Clinicopathological Characteristics of Lacrimal Gland Pleomorphic Adenoma and Mechanism of Tumorigenesis by the Imbalance Between Apoptosis and Proliferation.
Lv M, Dong Z, Tong Y, Li T, Hei Y, Yang X
Med Sci Monit. 2021; 27:e929152.
PMID: 33737504
PMC: 7986817.
DOI: 10.12659/MSM.929152.
Ductal Adenocarcinoma Ex Pleomorphic Adenoma of the Lacrimal Gland: a Rare and Morbid Malignancy.
Ashok Kumar P, Paulraj S, Mirchia K, Hahn S, Sivapiragasam A
Case Rep Oncol Med. 2020; 2020:1790106.
PMID: 32089922
PMC: 7021468.
DOI: 10.1155/2020/1790106.
Clinical Management of Acinic Cell Carcinoma of the Lacrimal Gland.
Anesi A, Negrello S, Lucchetti D, Pollastri G, Trevisiol L, Badiali L
Case Rep Oncol. 2019; 12(3):777-790.
PMID: 31762749
PMC: 6872994.
DOI: 10.1159/000503557.
Immunohistochemical features of carcinoma ex pleomorphic adenoma and pleomorphic adenoma in the lacrimal gland.
Zhang P, Tang L, Gao H, Zhang W, Lin J, Yang H
Int J Ophthalmol. 2019; 12(8):1238-1242.
PMID: 31456912
PMC: 6694048.
DOI: 10.18240/ijo.2019.08.02.
Primary sebaceous carcinoma of lacrimal gland: A case report and review of literature.
Park H, Choi S
World J Clin Cases. 2019; 6(16):1194-1198.
PMID: 30613681
PMC: 6306633.
DOI: 10.12998/wjcc.v6.i16.1194.
Primary poorly differentiated lacrimal gland adenocarcinoma in left ocular region: A rare case report.
Xia F, Ling W, Zhang J, Zhang Y, Ma X
Medicine (Baltimore). 2018; 97(37):e12198.
PMID: 30212949
PMC: 6156032.
DOI: 10.1097/MD.0000000000012198.
Lacrimal gland adenocarcinoma responding to checkpoint inhibition and androgen deprivation.
Bulbul A
Oxf Med Case Reports. 2018; 2018(9):omy066.
PMID: 30159157
PMC: 6109195.
DOI: 10.1093/omcr/omy066.
Lacrimal gland tumors in Turkey: types, frequency, and outcomes.
Yesiltas Y, Gunduz A, Erden E, Shields C
Int J Ophthalmol. 2018; 11(8):1296-1302.
PMID: 30140632
PMC: 6090115.
DOI: 10.18240/ijo.2018.08.08.
Non-sebaceous lymphadenoma of the lacrimal gland: first report of a new localization.
Pau M, Brcic L, Seethala R, Klein-Theyer A, Magyar M, Reinbacher K
Virchows Arch. 2018; 473(1):127-130.
PMID: 29460186
DOI: 10.1007/s00428-018-2322-4.
Lacrimal myoepithelial carcinoma ex recurrent pleomorphic adenoma: A clinicopathological report and review of the literature.
Larbcharoensub N, Pangpunyakulchai D, Aroonroch R, Tuntiyatorn L, Mahaisavariya P
Mol Clin Oncol. 2018; 8(1):209-213.
PMID: 29387416
PMC: 5769277.
DOI: 10.3892/mco.2017.1488.